Target intelligence / Profile preview

Airway Resistance Reduction via Low-Density Gas Flow

01

Overview

Airway Resistance Reduction via Low-Density Gas Flow describes a therapeutic approach rather than a specific molecular target. It involves the substitution of nitrogen with helium to reduce gas density and Reynolds number, promoting laminar flow and reducing turbulent flow-related resistance in large airways.

Other names
Heliox therapy (for airway resistance reduction)Low-density gas therapy for airway obstruction
02

Mechanism of action

Substitution of nitrogen with helium reduces gas density and Reynolds number, promoting laminar flow and reducing turbulent flow-related resistance in large airways. In small airways where flow is already laminar and independent of density, this effect is minimal. The main benefit occurs in large airways where turbulent flow predominates. The Hagen–Poiseuille equation governs laminar flow resistance; under these conditions, only viscosity matters. For turbulent or transitional flows in larger airways, reduced density decreases resistance.

03

Biological functions

Reduction of airway resistance during breathingFacilitation of laminar flow in airways
04

Disease associations

AsthmaChronic obstructive pulmonary disease (COPD)Upper and lower airway obstruction (e.g., croup, epiglottitis, foreign body, tumor, tracheal stenosis)
05

Safety considerations

High cost compared to oxygen therapyLimited availability of heliox mixturesRequires recalibration of ventilators when used with mechanical ventilation due to altered physical properties of the gas mixtureMay reduce efficiency of coughing due to altered vocal pitch and airflow dynamics

Beyond the preview

Go deeper on Airway Resistance Reduction via Low-Density Gas Flow.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Airway Resistance Reduction via Low-Density Gas Flow.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call